BGC > Product Search > (5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxo-decahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide | 1071992-99-8
Suppliers for CAS
1071992-99-8
(5S,8S,10aR)-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-3-(3-methylbutanoyl)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
|
Properties | CAS |
1071992-99-8 | Formula |
C32H43N5O4 |
|
|
6 Registered suppliers
Amadis Chemical Company Limited
P.R.China
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C32H43N5O4 Molecular Weight: 561.71492 UN Number: 3077 HS Code: 29339900
Aea.ltd
P.R.China
Molecular Formula: C32H43N5O4 Molecular Weight: 561.71492 UN Number: 3077 HS Code: 29339900
BOC Sciences
USA
Description : AT-406 is a potent Smac mimetic and an antagonist of IAP (inhibitor of apoptosis protein via E3 ubiquitin ligase), binding to XIAP-BIR3 (with Ki of 66.4 nM), cIAP1-BIR3(with Ki of 1.9 nM) and cIAP2-BIR3 (with Ki of 5.1 nM), respectively. - Molecular Weight :561.71
- Purity :> 98%
Molecular Formula : C32H43N5O4 Canonical SMILES : CC(C)CC(=O)N1CCC2CCC(N2C(=O)C(C1)NC(=O)C(C)NC)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4 InChI : InChI=1S/C32H43N5O4/c1-21(2)19-28(38)36-18-17-25-15-16-27(37(25)32(41)26(20-36)34-30(39)22(3)33-4)31(40)35-29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-14,21-22,25-27,29,33H,15-20H2,1-4H3,(H,34,39)(H,35,40)/t22-,25+,26-,27-/m0/s1 InChIKey : LSXUTRRVVSPWDZ-MKKUMYSQSA-N Appearance : Solid Powder Synonyms : AT406; AT 406; SM-406; SM 406; SM406; ARRY-334543; ARRY 334543; ARRY334543
More details are to be found here
BLD Pharmatech Ltd
P.R.China
Smile code: O=C([C@@H]1CC[C@@](CCN(C(CC(C)C)=O)C[C@@H]2NC([C@@H](NC)C)=O)([H])N1C2=O)NC(C3=CC=CC=C3)C4=CC=CC=C4 MDL Number: MFCD22124467 Purity : 98% Available in stock: 11 g
More details are to be found here
Chemlyte Solutions
P.R.China
(5S,8S,10aR)-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-3-(3-methylbutanoyl)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
details
More details are to be found here
|